Nutrition Facts with Dr. Greger

More on Boosting NAD+

Sep 18, 2025
Delve into the intriguing world of NAD+ boosters and discover the battle between NMN and NR. Learn about the limited benefits shown in human trials, including mixed exercise outcomes. Explore the potential risks of lesser-known supplements like tryptophan and the challenges of oral NAD forms. The discussion highlights safety concerns and product mislabeling, revealing a complex landscape of NAD+ supplementation. Throughout, the emphasis is on understanding how these substances interact with our bodies.
Ask episode
AI Snips
Chapters
Books
Transcript
Episode notes
INSIGHT

NMN vs NR: Similar Yet Unsettled

  • NMN and NR both raise NAD in animals and humans but haven't been compared directly head-to-head in people.
  • NMN may be more stable in blood and is a direct NAD precursor, but cell entry is debated due to its phosphate group.
INSIGHT

NMN Cell Entry Is Controversial

  • NMN carries a phosphate that may prevent cell membrane passage, requiring conversion to NR to enter cells.
  • A proposed NMN transporter in mouse intestines could allow direct NMN uptake, but evidence remains controversial.
INSIGHT

Human Evidence For NMN Is Limited

  • NMN shows many rodent healthspan benefits but no demonstrated lifespan extension in mammals yet.
  • Human trials are few and have not shown convincing broad benefits beyond transient blood NAD raises.
Get the Snipd Podcast app to discover more snips from this episode
Get the app